1. Pneumonia in young adults with asthma: impact on subsequent asthma exacerbations
- Author
-
Pelton SI, Shea KM, Bornheimer R, Sato R, and Weycker D
- Subjects
Pneumonia ,asthma ,disease exacerbation ,disease progression ,Immunologic diseases. Allergy ,RC581-607 - Abstract
Stephen I Pelton,1,2 Kimberly M Shea,1 Rebecca Bornheimer,3 Reiko Sato,4 Derek Weycker31Department of Epidemiology, Boston University Schools of Medicine and Public Health, Boston, MA, USA; 2Maxwell Finland Laboratories, Boston Medical Center, Boston, MA, USA; 3Policy Analysis Inc. (PAI), Brookline, MA, USA; 4Health Economic & Outcomes Research, Pfizer Inc., Collegeville, PA, USABackground: Recent studies of community-acquired pneumonia (CAP) have recognized acute cardiac complications—such as myocardial infarction, arrhythmia, or congestive heart failure (CHF)—as frequent complications during the acute process. As well, a prolonged vulnerability to exacerbations of underlying comorbidities—such as CHF and COPD—has been observed following CAP. We hypothesized that young adults with underlying asthma could also be adversely impacted over a prolonged time period following CAP.Methods: Using a retrospective matched-cohort design and data from a US private healthcare claims repository (>15 M persons annually), we selected all adults 18–49 years of age with evidence of asthma as their only comorbidity for inclusion in the source population. Then, from the source population, we matched one comparison patient to each CAP patient based on index date, age, sex, and selected markers for health status (eg, history of asthma-related healthcare encounters), and evaluated subsequent outpatient and inpatient encounters for asthma exacerbations.Results: Asthma exacerbations were identified twice as often in the 12 months subsequent to acute CAP. Cumulative incidence proportions for asthma exacerbations requiring hospitalization or emergency department care after 12 months of follow-up were 19.9% for those previously hospitalized with CAP versus 9.0% for matched comparison patients (difference, 10.9%; p
- Published
- 2019